President Trump has complained that drug makers are getting away with murder — and he may be right.
Despite vociferous complaints from consumers that drug prices are too high, Congress has failed to act. And with few exceptions, the pharmaceutical industry has successfully delayed or thwarted state bills that would force drug makers to explain or justify price hikes.
But that may be starting to change. Last week, to the fury of the pharma industry, California enacted a law demanding transparency on rising medicine costs. Vermont already has a similar policy in place. Nevada recently began requiring drug makers to disclose pricing data about diabetes medicines. And Maryland has a new law that penalizes generic companies for price gouging.
About the Author Reprints
talk to me when any of these proposed bills becomes law